Fenoglide
Links shared publicly online about this topic
Impax Laboratories Confirms Patent Challenge Relating To Fenoglide(R) 40 And 120 Mg Tablets
medicalnewstoday.com — “Impax Laboratories, Inc. (NASDAQ:IPXL) confirms that it has initiated a challenge of a patent listed by Shionogi Pharma, Inc. in connection with its Fenoglide® (fenofibrate) tablets, 40 and 12” View full resource at medicalnewstoday.com
Most Recently Shared on May 2, 2010 at 12:05 pm By:
Impax Laboratories Confirms Patent Challenge Relating To Fenoglide(R) 40 And 120 Mg Tablets http://mnt.to/3BZK #pharmacy #pharmacist
The Top 3 resources shared on this topic. More resources.
Key stats and trends about this topic
Related WisdomCards
Featuring the top 3 experts for this topic
-
MNT Pharmacy News
The latest pharmacy / pharmacist news published daily. Articles from research centers, universities and prestigious journals.
Advertisement
